×
About 12,655 results

ALLMedicine™ Uveitis Center

Research & Reviews  3,654 results

Risk of uveitis in patients with psoriasis in Korea: A nationwide population-based coho...
https://doi.org/10.1111/jdv.19060
Journal of the European Academy of Dermatology and Venere... Kim BR, Choi SW et. al.

Mar 24th, 2023 - Evidence for the association between psoriasis and uveitis according to the severity of psoriasis including psoriatic arthritis (PsA) and type of uveitis is lacking, and there are no data on the frequency or timing of recurrence of uveitis in pati...

Inflammatory eye disease for rheumatologists.
https://doi.org/10.1097/BOR.0000000000000933
Current Opinion in Rheumatology; Corbitt K, Nowatzky J

Mar 22nd, 2023 - This review provides a framework for understanding inflammatory eye disease diagnosis, differential diagnosis, and management for rheumatologists. Uveitis, scleritis, episcleritis, peripheral ulcerative keratitis, and orbital inflammation are all ...

Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflam...
https://doi.org/10.1080/1744666X.2023.2193687
Expert Review of Clinical Immunology; Bitossi A, Mattioli I et. al.

Mar 21st, 2023 - Noninfectious uveitis related to systemic inflammatory diseases represents a leading cause of blindness. Anti-TNFα agents are the first-line biologic therapy after traditional immunosuppressants, for ocular and systemic involvement. However, some ...

Five-year Clinical Outcomes of Inferior Quadrant Trabectome Surgery for Open Angle Glau...
https://doi.org/10.1097/IJG.0000000000002164
Journal of Glaucoma; Weber C, Ludwig E et. al.

Mar 18th, 2023 - This retrospective study of 264 eyes having inferior-quadrant trabectome surgery confirms its safety and relatively effectiveness. Most patients however still require IOP-lowering agents and a considerable proportion may need additional glaucoma s...

Incidence and pre/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease.
https://doi.org/10.1007/s10792-023-02688-0
International Ophthalmology; Yoshitomi S, Harada Y et. al.

Mar 18th, 2023 - To investigate the incidence and pre/post-treatment risk factors of glaucoma in patients with Vogt-Koyanagi-Harada (VKH) disease. Data regarding secondary glaucoma were collected from the medical records of patients with VKH disease who were follo...

see more →

Guidelines  7 results

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tuber...
https://doi.org/10.1016/j.ophtha.2020.06.052
Ophthalmology Agrawal R, Testi I et. al.

Jul 1st, 2020 - The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to de...

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tuber...
https://doi.org/10.1016/j.ophtha.2020.01.008
Ophthalmology Agrawal R, Testi I et. al.

Mar 3rd, 2020 - An international, expert-led consensus initiative organized by the Collaborative Ocular Tuberculosis Study (COTS), along with the International Ocular Inflammation Society and the International Uveitis Study Group, systematically developed evidenc...

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884654
Arthritis Care & Research; Angeles-Han ST, Ringold S et. al.

Apr 26th, 2019 - To develop recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis (JIA). Pediatric rheumatologists, ophthalmologists with expertise in uveitis, patient representatives, and methodolog...

Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Ju...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261704
Arthritis Care & Research; Angeles-Han ST, Lo MS et. al.

May 29th, 2018 - Systemic immunosuppressive treatment of pediatric chronic anterior uveitis (CAU), both juvenile idiopathic arthritis-associated and idiopathic anterior uveitis, varies, making it difficult to identify best treatments. The Childhood Arthritis and R...

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveiti...
https://doi.org/10.1016/j.ophtha.2017.11.017
Ophthalmology Dick AD, Rosenbaum JT et. al.

Jan 10th, 2018 - An international, expert-led consensus initiative to develop systematic, evidence-based recommendations for the treatment of noninfectious uveitis in the era of biologics. The availability of biologic agents for the treatment of human eye disease ...

see more →

Drugs  598 results see all →

Clinicaltrials.gov  407 results

Intestinal Bacteria and Ocular Inflammatory Disease
https://clinicaltrials.gov/ct2/show/NCT01859299

Mar 9th, 2023 - Objective: What precipitates ocular inflammatory episodes remains unknown, but a possible potentiating factor is the microbiome. The microbiome has become increasingly studied with the advent of new techniques, but these have not been applied to u...

Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
https://clinicaltrials.gov/ct2/show/NCT05608837

Mar 7th, 2023 - LEOPARD is a prospective, multi-center, single masked, randomized, controlled, study. At least 24 eligible subjects (12 with Uveitic macular edema and 12 with Post surgical macular edema) are to be enrolled in the study. There will be 5 sites and ...

Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis
https://clinicaltrials.gov/ct2/show/NCT05384249

Mar 3rd, 2023 - Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin-17A, to which it binds with high affinity. This study investigates izokibep in subjects with active non-infectious, intermediate-, posterior- or pan-uve...

The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
https://clinicaltrials.gov/ct2/show/NCT00331331

Mar 3rd, 2023 - Newer therapies to treat many ocular disorders including uveitis are being considered and studied. We do not have a clear picture as to what lymphokines/chemokines are present in the vitreous or anterior chamber fluid of patients with active intra...

A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
https://clinicaltrials.gov/ct2/show/NCT05523765

Mar 1st, 2023 - This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with active intermediate, posterior, or pan non-infectious uveitis (NIU).

see more →

News  376 results

Woman Seeks Answers After 3 Years of Painful Genital Ulcers
https://www.medpagetoday.com/dermatology/generaldermatology/102873

Jan 30th, 2023 - A woman in her late 40s presented with painful ulcers in her groin and armpits that hadn't healed in 3 years, an Indian group reported in JAMA Dermatology. The woman explained that when the sores first appeared, they were just itchy, oozing, reddi...

PsA-related uveitis: Real-world data on epidemiology and clinical features
https://www.mdedge.com/rheumatology/article/260852/psoriatic-arthritis/psa-related-uveitis-real-world-data-epidemiology-and

Jan 26th, 2023 - Key clinical point: Uveitis related to psoriatic arthritis (PsA) had a prevalence of approximately 5%, presented as an acute and recurrent disease with anterior and unilateral involvement, and was associated with impaired quality of life and incre.

Axial PsA: A distinct phenotype not to be confused with ankylosing spondylitis+psoriasis
https://www.mdedge.com/rheumatology/article/260157/psoriatic-arthritis/axial-psa-distinct-phenotype-not-be-confused

Dec 14th, 2022 - Key clinical point: Axial psoriatic arthritis (PsA) can be categorized as a distinct subtype of PsA because it exhibits clinical and radiological symptoms that are different from those of ankylosing spondylitis (AS) with psoriasis. Major finding:.

FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancer
https://www.medpagetoday.com/hematologyoncology/ovariancancer/101748

Nov 15th, 2022 - The FDA granted accelerated approval for the antibody-drug conjugate (ADC) mirvetuximab soravtansine (Elahere) for folate receptor α (FRα)-positive platinum-resistant ovarian cancer. The action makes mirvetuximab the first ADC with an indication f...

New ACR/EULAR Guideline Expands RA Remission Definition
https://www.medpagetoday.com/rheumatology/arthritis/101403

Oct 25th, 2022 - Newly released guidance for defining remission in rheumatoid arthritis (RA) is expected to increase the number of patients achieving it while maintaining its ability to predict good objective outcomes. The more relaxed criteria from the American C...

see more →

Patient Education  20 results see all →